Teva Surges On Profit Guidance Boost Despite A Mixed First-Quarter Report

investors.com/news/technology/teva-stock-teva-pharmaceutical-earnings-q1-2025/?src=A00220

Teva stock shot higher early Wednesday after the drugmaker reported adjusted earnings of 52 cents per share on $3.89 billion in first-quarter sales.
On average, analysts polled by FactSet expected Teva Pharmaceutical (TEVA) to earn 47 cents per share on $4.06 billion in sales. In the…

This story appeared on investors.com, 2025-05-07 12:47:42.
The Entire Business World on a Single Page. Free to Use →